Amanys Pharma

What Amanys Pharma does

Amanys Pharma is a privately held Moroccan pharmaceutical manufacturer founded in 2011 and headquartered in Aïn El Aouda. The company's stated business is the production of antibiotics and hospital specialty drugs for the Moroccan healthcare market, positioning it as a domestic-focused generic and specialty pharma manufacturer rather than an exporter or innovative-drug developer. With a headcount of 51-100 employees, it operates at small-to-mid-market scale relative to North African pharmaceutical peers, and its customer base is implied to be institutional — primarily Moroccan hospitals, clinics, and pharmacy distributors that procure antibiotics and hospital-channel specialty products.

The firm's business model is conventional B2B pharmaceutical manufacturing: it produces antibiotics and hospital specialty drugs, presumably under manufacturing licenses and product-level regulatory approvals issued by Moroccan health authorities, and sells into the hospital and pharmacy distribution channel. The input data provides no specifics on product portfolio breadth, pricing model, distribution agreements, key account relationships, or capital structure, so the mechanics of revenue capture — tender-based vs. negotiated hospital contracts vs. wholesale pharmacy supply — cannot be confirmed from the available evidence.

Substantive primary-source data is materially constrained. The only direct source attempt resolved to a loading/verification page on the company's own website (amanyspharma.com) and yielded no content on products, leadership, financials, partnerships, or history. No funding rounds, M&A activity, leadership disclosures, certification details, awards, or geographic expansion signals are recorded. Any deeper analysis of revenue mix, customer concentration, growth trajectory, or AI/technology stack would require access to Moroccan health authority filings, import/export records, and direct company diligence.

Name

Amanys Pharma

Website

https://amanyspharma.com

Company type

Private

Founded year

2011

Headcount range

51–100 employees

Short description

Amanys Pharma is a privately held Moroccan pharmaceutical manufacturer founded in 2011, producing antibiotics and hospital specialty drugs for the domestic healthcare market from its Aïn El Aouda headquarters with 51-100 employees.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIAAAG

Infectious Disease & Antimicrobials Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIABAH

Generic Finished Dosage Form (FDF) Manufacturing

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

Keywords

• Antibiotic manufacturing
• Hospital specialty drugs
• Pharmaceutical production
• Essential medicines
• Generic pharmaceuticals

Headquarters

HQ city

Aïn El Aouda

HQ country

Morocco

HQ region

Africa

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Amanys Pharma is a Moroccan pharmaceutical manufacturer that produces antibiotics and hospital specialty drugs. Founded in 2011 and headquartered in Aïn El Aouda, the company operates a manufacturing facility employing 51–100 staff to supply essential and specialty medications intended for use by Moroccan hospitals and healthcare buyers. The product line focuses on antimicrobial and hospital-use therapeutic categories serving the Moroccan healthcare market.

Differentiator

Problem solved

Functional benefit

Products and services

• Antibiotics Amanys Pharma manufactures antibiotics targeted at the Moroccan healthcare market, intended for use by hospitals and healthcare institutions. Specific antibiotic SKUs, formulations, dosages, and indications are not publicly detailed in the available source material beyond the category-level description of antibiotic manufacturing.
• Hospital specialty drugs Amanys Pharma manufactures hospital specialty drugs intended for use in Moroccan hospitals. Specific specialty drug formulations, therapeutic areas, branded names, and product-level launch dates are not publicly documented in the available source material.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• Cooper Pharma: Leading Moroccan pharmaceutical manufacturer producing generics and hospital medicines including antibiotics. Direct domestic competitor serving the same hospital and pharmacy channels as Amanys Pharma.
• Bottu SA: Historic Moroccan pharmaceutical manufacturer of generic and branded finished dosage forms. Comparable as a Morocco-based manufacturer competing for the same hospital and retail accounts.
• Galenica (Maroc): Moroccan generic pharmaceutical manufacturer with a broad portfolio including anti-infectives and hospital specialty products. Operates in the same local market with a similar manufacturing and distribution profile.

Broad incumbents

• Sanofi Maroc: Moroccan affiliate of a global pharma major, manufacturing and distributing branded and generic medicines including antibiotics and hospital drugs. Comparable as a larger, multi-portfolio competitor in the same therapeutic categories.
• Hikma Pharmaceuticals: MENA-headquartered pharmaceutical company specializing in generics, injectables, and hospital-focused products including antibiotics. Comparable business model and channel mix to Amanys, though operating at global scale.
• Aspen Pharmacare: Africa's largest pharmaceutical manufacturer with significant presence in generics, anti-infectives, and hospital specialty products. Comparable as a regional incumbent producing in the same categories Amanys targets.

Regional players

• Medis (Les Laboratoires Medis): Tunisian pharmaceutical manufacturer producing generics including anti-infectives and hospital injectable products. Comparable as a Maghreb-region manufacturer operating in similar therapeutic categories.

Emerging players

• Cipla: Indian global generic manufacturer with one of the world's largest antibiotics and anti-infective portfolios, exporting into Africa. Comparable as a cost-competitive generics producer competing for the same downstream institutional buyers.
• Aurobindo Pharma: Indian generic manufacturer with a leading antibiotics franchise and growing presence in injectable and hospital dosage forms across Africa and emerging markets. Comparable on therapeutic category and channel mix.
• Strides Pharma Science: Indian generic manufacturer with strong presence in Africa and emerging markets, particularly in anti-infectives and institutional/hospital-tender business. Comparable in targeting the same generic antibiotics opportunity.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/amanys-pharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amanys Pharma